METHODS: All primary study designs including qualitative, quantitative, and mixed methods studies that reported on the experiences, treatment approaches and outcomes of MBC were included in this systematic review. Six databases (Embase, Medline, PsycINFO, Global Health, CINAHL and Web of Science) were searched for articles from January 2000 to September 2023. A results-based convergence synthesis was used for data analysis and reported using PRISMA guidelines.
RESULTS: Of the studies screened (n = 29,687), forty-four fulfilled the predetermined criteria and were included. Our findings relating to the experiences and treatment approaches of MBC are broadly themed into three parts. Theme 1-Navigating through a threat to masculinity: describes how males experienced the illness reflecting on detection, diagnosis, coming to terms with breast cancer, and disclosure. Theme 2- Navigating through treatment: captures the experiences of undergoing breast cancer treatment/ management following their diagnosis. Theme 3-Coping and support systems: describes how MBC patients coped with the disease, treatment process, aftercare/rehabilitative care, and the available support structures.
CONCLUSIONS: Men experience a myriad of issues following a breast cancer diagnosis, especially with their masculinity. Awareness creation efforts of MBC among the public and healthcare practitioners are urgently required, which could change the perception of men in promoting early diagnosis, adherence to treatments, post-treatment monitoring, oncological results and a better quality of life. Considerations for training, education and development of specialised guidelines for healthcare practitioners on MBC would provide the necessary knowledge and skills to enhance their practice through the adoption of person-centred and male-specific care strategies. Professional care intervention and support for MBC should not end after the diagnosis phase but should extend to the entire treatment continuum and aftercare including future research focusing on MBC specific clinical trials.
BACKGROUND: PROSPERO Registration No. CRD42021228778.
方法:所有主要研究设计,包括定性,定量,以及报告经验的混合方法研究,本系统综述包括MBC的治疗方法和结局.六个数据库(Embase,Medline,PsycINFO,全球卫生,CINAHL和WebofScience)搜索了2000年1月至2023年9月的文章。基于结果的收敛综合用于数据分析,并使用PRISMA指南进行报告。
结果:在筛选的研究中(n=29,687),44人符合预定标准,被列入。我们与MBC的经验和治疗方法有关的发现大致分为三个部分。主题1-通过对男性气质的威胁导航:描述男性如何经历疾病,反映在检测,诊断,接受乳腺癌,和披露。主题2-通过治疗导航:捕获在诊断后接受乳腺癌治疗/管理的经验。主题3-应对和支持系统:描述MBC患者如何应对疾病,处理过程,善后/康复护理,和可用的支撑结构。
结论:男性在乳腺癌诊断后经历了无数的问题,尤其是他们的阳刚之气.迫切需要在公众和医疗保健从业人员中开展MBC的意识创建工作,这可能会改变男性促进早期诊断的看法,坚持治疗,治疗后监测,肿瘤结果和更好的生活质量。对培训的考虑,MBC专业医疗从业者的教育和发展将提供必要的知识和技能,通过采用以人为本和针对男性的护理策略来加强他们的实践。对MBC的专业护理干预和支持不应在诊断阶段后结束,而应扩展到整个治疗连续体和后期护理,包括未来针对MBC特定临床试验的研究。
背景:PROSPERO注册号.CRD42021228778。